Document is current
Any future updates will be listed below
-
Authors
Peng, Shiwen
Fan, Darrell
Tu, Hsin-Fang
Cheng, Michelle
Arend, Rebecca C.
Levinson, Kimberly
Tao, Julia
Roden, Richard B. S.
Hung, Chien-Fu
Wu, T.-C. https://orcid.org/0000-0003-1623-4584
-
Funding
Funding for this research was provided by:
National Cancer Institute (P50CA098252, R01CA237067, R50CA251953)
- License Information
-
More Information
Article History
Received: 21 August 2024
Accepted: 16 December 2024
First Online: 25 December 2024
Declarations
:
: The animal study was approved by the Johns Hopkins University Animal Care and Use Committee and follow the Guide for the Care and Use of Laboratory Animals 8th ed (NRC 2011).
: All authors have reviewed and approved the following manuscript.
: Both Drs. Wu and Roden are co-founders of and have an equity ownership interest in Papivax LLC. Also, Drs. Wu and Roden own Papivax Biotech Inc. stock options and are members of Papivax Biotech Inc.'s Scientific Advisory Board. Under a licensing agreement between Papivax Biotech, Inc. and the Johns Hopkins University, the University and both Drs. Wu and Roden are entitled to royalties on a technology described in this article. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies.
